Sökresultat - "Targeting"

Within-Category Satiation and Cross-Category Spillover in Multiproduct Advertising.

Lu, Shijie¹ (AUTHOR) slyu@nd.edu, Yang, Sha² (AUTHOR) shayang@marshall.usc.edu, Yao, Yao (AUTHOR)

PEX5 acts as a negative regulator of RANKL-induced osteoclastogenesis in vitro and inflammatory calvarial bone destruction in vivo.

Eun SY; Musculoskeletal and Immune Disease Research Institute, School of Medicine, Wonkwang University, 460 Iksandae-ro, Iksan, Jeonbuk, 54538, Republic of Korea; Department of Pharmacology, School of Medicine, Wonkwang University, 460 Iksandae-ro, Iksan, 54538, Republic of Korea., Cheon YH; Musculoskeletal and Immune Disease Research Institute, School of Medicine, Wonkwang University, 460 Iksandae-ro, Iksan, Jeonbuk, 54538, Republic of Korea., Lee CH; Musculoskeletal and Immune Disease Research Institute, School of Medicine, Wonkwang University, 460 Iksandae-ro, Iksan, Jeonbuk, 54538, Republic of Korea; Division of Rheumatology, Department of Internal Medicine, Wonkwang University Hospital, 460 Iksandae-ro, Iksan, Jeonbuk, 54538, Republic of Korea., Chung CH; Musculoskeletal and Immune Disease Research Institute, School of Medicine, Wonkwang University, 460 Iksandae-ro, Iksan, Jeonbuk, 54538, Republic of Korea; Division of Rheumatology, Department of Internal Medicine, Wonkwang University Hospital, 460 Iksandae-ro, Iksan, Jeonbuk, 54538, Republic of Korea., Lee MS; Musculoskeletal and Immune Disease Research Institute, School of Medicine, Wonkwang University, 460 Iksandae-ro, Iksan, Jeonbuk, 54538, Republic of Korea; Division of Rheumatology, Department of Internal Medicine, Wonkwang University Hospital, 460 Iksandae-ro, Iksan, Jeonbuk, 54538, Republic of Korea. Electronic address: ckhlms@wku.ac.kr., Kim JY; Musculoskeletal and Immune Disease Research Institute, School of Medicine, Wonkwang University, 460 Iksandae-ro, Iksan, Jeonbuk, 54538, Republic of Korea. Electronic address: kimjy1014@gmail.com.

Journal Article; Research Support, Non-U.S. Gov't , 2025

Design, synthesis, and biological evaluation of novel PROTACs compounds with good ERα degradation ability.

Yang X; Department of Natural Product Chemistry, Key Laboratory of Chemical Biology of Ministry of Education, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan 250012, PR China; Shandong Qidu Pharmaceutical Research Institute, Zibo 255400, PR China., Zheng X; Shandong Qidu Pharmaceutical Research Institute, Zibo 255400, PR China., Liu C; Shandong Qidu Pharmaceutical Research Institute, Zibo 255400, PR China., Zheng J; Shandong Qidu Pharmaceutical Research Institute, Zibo 255400, PR China., Dong X; Shandong Qidu Pharmaceutical Research Institute, Zibo 255400, PR China., Ren W; Shandong Qidu Pharmaceutical Research Institute, Zibo 255400, PR China., Zhang T; Shandong Qidu Pharmaceutical Research Institute, Zibo 255400, PR China., Lou H; Department of Natural Product Chemistry, Key Laboratory of Chemical Biology of Ministry of Education, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan 250012, PR China. Electronic address: louhongxiang@sdu.edu.cn., Fan P; Department of Natural Product Chemistry, Key Laboratory of Chemical Biology of Ministry of Education, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan 250012, PR China. Electronic address: fanpeihong@sdu.edu.cn.

Journal Article , 2025

Challenges of Studying Amelogenesis in Gene-Targeted Mouse Models.

Smith CE; Department of Anatomy & Cell Biology, Faculty of Medicine & Health Sciences, McGill University, 3640 University St., Montreal, QC H3A 0C7, Canada.; Department of Biologic and Materials Sciences, University of Michigan School of Dentistry, 1011 North University Ave., Ann Arbor, MI 48190, USA., Bartlett JD; Division of Biosciences, College of Dentistry, Ohio State University, 305 W. 12th Ave., Columbus, OH 43210, USA., Simmer JP; Department of Biologic and Materials Sciences, University of Michigan School of Dentistry, 1011 North University Ave., Ann Arbor, MI 48190, USA., Hu JC; Department of Biologic and Materials Sciences, University of Michigan School of Dentistry, 1011 North University Ave., Ann Arbor, MI 48190, USA.

Journal Article; Review , 2025

Using multiple modalities to confirm diagnosis in patients with suspected peroxisome biogenesis disorders.

Cheung ACT; Division of Medical Genetics, Department of Specialized Medicine, McGill University Health Center, Montreal, Quebec, Canada., Di Pietro E; Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada., Argyriou C; Department of Human Genetics, McGill University, Montreal, Quebec, Canada; Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada., Bareke E; Department of Human Genetics, McGill University, Montreal, Quebec, Canada., D'Souza Y; Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada., Puri RD; Institute of Medical Genetics and Genomics, Sir Ganga Ram Hospital, Delhi, India., Muhammed Shabeer P; Institute of Medical Genetics and Genomics, Sir Ganga Ram Hospital, Delhi, India., Ganetzky R; Mitochondrial Medicine Frontier Program, Division of Human Genetics, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA, USA; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Goldstein A; Mitochondrial Medicine Frontier Program, Division of Human Genetics, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA, USA; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Vanderver A; Division of Neurology, Children's Hospital of Philadelphia, Philadelphia, PA, USA; Department of Neurology, Perlman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Mohan S; Department of Pathology, Duke University School of Medicine, Durham, NC, USA., Majewski J; Department of Human Genetics, McGill University, Montreal, Quebec, Canada., Yergeau C; Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada., Braverman N; Division of Medical Genetics, Department of Specialized Medicine, McGill University Health Center, Montreal, Quebec, Canada; Departments of Human Genetics and Pediatrics, McGill University, Montreal, Quebec, Canada; Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada. Electronic address: nancy.braverman@mcgill.ca.

Journal Article; Case Reports , 2025

Protein-targeting reverse genetic approaches: the future of oocyte and preimplantation embryo research.

Camlin NJ; Cell and Molecular Biology, School of Biological, Environmental and Earth Sciences, The University of Southern Mississippi, Hattiesburg, MS, USA.

Journal Article; Review , 2025

AT1, a small molecular degrader of BRD4 based on proteolysis targeting chimera technology alleviates renal fibrosis and inflammation in diabetic nephropathy.

Yang M; School of Basic Medicine, Gannan Medical University, Ganzhou 341000, China., Li J; School of Pharmacy, Gannan Medical University, Ganzhou 341000, China., Huang X; School of Basic Medicine, Gannan Medical University, Ganzhou 341000, China., Jin S; School of Basic Medicine, Gannan Medical University, Ganzhou 341000, China., Wan S; School of Basic Medicine, Gannan Medical University, Ganzhou 341000, China., Wu S; School of Basic Medicine, Gannan Medical University, Ganzhou 341000, China. Electronic address: wusuzhen2005@126.com.

Journal Article , 2025

Beyond a few bases: methods for large DNA insertion and gene targeting in plants.

Vollen K; Department of Plant Biology, North Carolina State University, Raleigh, North Carolina, 27695, USA., Alonso JM; Department of Plant Biology, North Carolina State University, Raleigh, North Carolina, 27695, USA., Stepanova AN; Department of Plant Biology, North Carolina State University, Raleigh, North Carolina, 27695, USA.

Journal Article; Review , 2025

Identification of a Potent and Selective CDK9 Degrader as a Targeted Therapeutic Option for the Treatment of Small-Cell Lung Cancer.

Wang Y; The State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, Nankai University, Tianjin 300071, P. R. China., Wang M; The State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, Nankai University, Tianjin 300071, P. R. China., Ma L; The State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, Nankai University, Tianjin 300071, P. R. China., Zhang Y; The State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, Nankai University, Tianjin 300071, P. R. China., Jiao Y; The State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, Nankai University, Tianjin 300071, P. R. China., Zhang S; The State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, Nankai University, Tianjin 300071, P. R. China., Yang Y; The State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, Nankai University, Tianjin 300071, P. R. China., Li J; The State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, Nankai University, Tianjin 300071, P. R. China., Wei M; The State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, Nankai University, Tianjin 300071, P. R. China., Cao S; The State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, Nankai University, Tianjin 300071, P. R. China.; College of Food Science and Pharmaceutical Engineering, Zaozhuang University, Zaozhuang, Shandong 277160, China., Zhang K; The State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, Nankai University, Tianjin 300071, P. R. China., Liu S; The State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, Nankai University, Tianjin 300071, P. R. China., Yang G; The State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, Nankai University, Tianjin 300071, P. R. China.

Journal Article , 2025

Discovery of a potent PARP1 PROTAC as a chemosensitizer for the treatment of colorectal cancer.

Wu M; Institute of Drug Discovery and Design, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China., Jiang Y; Research Center for Clinical Pharmacy, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China., Zhang D; Research Center for Clinical Pharmacy, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China., Wu Y; Institute of Drug Discovery and Design, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China., Jin Y; Key Laboratory of Neuropsychiatric Drug Research of Zhejiang Province, Hangzhou Medical College, Hangzhou, 310058, China., Liu T; Institute of Drug Discovery and Design, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China., Mao X; Institute of Drug Discovery and Design, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China., Yu H; Institute of Modern Chinese Medicine, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China., Xu T; Institute of Modern Chinese Medicine, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China., Chen Y; Institute of Modern Chinese Medicine, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China., Huang W; Key Laboratory of Neuropsychiatric Drug Research of Zhejiang Province, Hangzhou Medical College, Hangzhou, 310058, China., Che J; Institute of Drug Discovery and Design, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China; State Key Laboratory of Advanced Drug Delivery and Release Systems, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310009, China., Zhang B; Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou, 310024, China; Westlake Laboratory of Life Sciences and Biomedicine of Zhejiang Province, Hangzhou, 310024, China., Liu T; Institute of Drug Discovery and Design, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China; State Key Laboratory of Advanced Drug Delivery and Release Systems, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310009, China. Electronic address: lt601@zju.edu.cn., Lin N; Research Center for Clinical Pharmacy, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China; Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou, 310024, China; Westlake Laboratory of Life Sciences and Biomedicine of Zhejiang Province, Hangzhou, 310024, China. Electronic address: lnm1013@zju.edu.cn., Dong X; Institute of Drug Discovery and Design, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China; Department of Pharmacy, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, China; State Key Laboratory of Advanced Drug Delivery and Release Systems, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310009, China. Electronic address: dongxw@zju.edu.cn.

Journal Article , 2025

Discovery of a highly potent, N-terminal domain-targeting degrader of AR-FL/AR-V7 for the treatment of prostate cancer.

Ha S; State Key Laboratory of Natural Medicines and Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing, 211198, China., Ji C; State Key Laboratory of Natural Medicines and Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing, 211198, China., Yang J; State Key Laboratory of Natural Medicines and Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing, 211198, China., Xiao M; State Key Laboratory of Natural Medicines and Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing, 211198, China., Xu Z; Department of Chemistry, Boston University, Boston, MA, 02215, United States., Pan WW; Department of Cell Biology, College of Medicine, Jiaxing University, Jiaxing, 314001, China., Xiang H; State Key Laboratory of Natural Medicines and Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing, 211198, China. Electronic address: xianghua@cpu.edu.cn., Luo G; State Key Laboratory of Natural Medicines and Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing, 211198, China. Electronic address: gsluo@cpu.edu.cn.

Journal Article , 2025

Genetic targeting of myelinated primary afferent neurons using a new Nefh ^CreERT2 knock-in mouse.

Chen JC; Division of Cell- and Neurobiology, Department of Biomedical and Clinical Sciences, Linköping University, 581 85, Linköping, Sweden., Kaczmarczyk L; Division of Cell- and Neurobiology, Department of Biomedical and Clinical Sciences, Linköping University, 581 85, Linköping, Sweden., de-Faria FM; Department of Biomedical and Clinical Sciences, Center for Social and Affective Neuroscience, Linköping University, 581 85, Linköping, Sweden., Szczot M; Department of Biomedical and Clinical Sciences, Center for Social and Affective Neuroscience, Linköping University, 581 85, Linköping, Sweden., Jackson WS; Division of Cell- and Neurobiology, Department of Biomedical and Clinical Sciences, Linköping University, 581 85, Linköping, Sweden., Larsson M; Division of Cell- and Neurobiology, Department of Biomedical and Clinical Sciences, Linköping University, 581 85, Linköping, Sweden. max.larsson@liu.se.

Journal Article , 2025

Improvement of Targeting Efficiency by Promoter Replacement of Markers in Integration Vectors.

Matsuyama A; Molecular Ligand Target Research Team, RIKEN Center for Sustainable Resource Science, Wako, Saitama, Japan.; Chemical Genomics Research Group, RIKEN Center for Sustainable Resource Science, Wako, Saitama, Japan.; Laboratory of Microbiology, Department of Biotechnology, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Bunkyo-ku, Tokyo, Japan., Hashimoto A; Chemical Genomics Research Group, RIKEN Center for Sustainable Resource Science, Wako, Saitama, Japan., Arioka M; Laboratory of Microbiology, Department of Biotechnology, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.; Collaborative Research Institute for Innovative Microbiology (CRIIM), The University of Tokyo, Bunkyo-ku, Tokyo, Japan., Yoshida M; Chemical Genomics Research Group, RIKEN Center for Sustainable Resource Science, Wako, Saitama, Japan.; Collaborative Research Institute for Innovative Microbiology (CRIIM), The University of Tokyo, Bunkyo-ku, Tokyo, Japan.; Office of University Professor, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.

Journal Article , 2025

In vivo expansion of gene-targeted hepatocytes through transient inhibition of an essential gene.

De Giorgi M; Department of Integrative Physiology, Baylor College of Medicine, Houston, TX 77030, USA., Park SH; Department of Bioengineering, Rice University, Houston, TX 77030, USA., Castoreno A; Alnylam Pharmaceuticals Inc., Cambridge, MA 02142, USA., Cao M; Department of Bioengineering, Rice University, Houston, TX 77030, USA., Hurley A; Department of Integrative Physiology, Baylor College of Medicine, Houston, TX 77030, USA., Saxena L; Department of Bioengineering, Rice University, Houston, TX 77030, USA., Chuecos MA; Department of Integrative Physiology, Baylor College of Medicine, Houston, TX 77030, USA.; Translational Biology and Molecular Medicine Program, Baylor College of Medicine, Houston, TX 77030, USA., Walkey CJ; Department of Integrative Physiology, Baylor College of Medicine, Houston, TX 77030, USA., Doerfler AM; Department of Integrative Physiology, Baylor College of Medicine, Houston, TX 77030, USA., Furgurson MN; Department of Integrative Physiology, Baylor College of Medicine, Houston, TX 77030, USA., Ljungberg MC; Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA.; Duncan Neurological Research Institute, Texas Children's Hospital, Houston, TX 77030, USA., Patel KR; Department of Pathology, Texas Children's Hospital, Houston, TX 77030, USA., Hyde S; Alnylam Pharmaceuticals Inc., Cambridge, MA 02142, USA., Chickering T; Alnylam Pharmaceuticals Inc., Cambridge, MA 02142, USA., Lefebvre S; Alnylam Pharmaceuticals Inc., Cambridge, MA 02142, USA., Wassarman K; Alnylam Pharmaceuticals Inc., Cambridge, MA 02142, USA., Miller P; Alnylam Pharmaceuticals Inc., Cambridge, MA 02142, USA., Qin J; Alnylam Pharmaceuticals Inc., Cambridge, MA 02142, USA., Schlegel MK; Alnylam Pharmaceuticals Inc., Cambridge, MA 02142, USA., Zlatev I; Alnylam Pharmaceuticals Inc., Cambridge, MA 02142, USA., Han J; Division of Medical Sciences, University of Victoria, Victoria, BC V8P 5C2, Canada.; UVic-GBC Proteomics Centre, Department of Biochemistry and Microbiology, University of Victoria, Victoria, BC V8P 5C2, Canada., Beeton C; Department of Integrative Physiology, Baylor College of Medicine, Houston, TX 77030, USA., Li RG; Department of Integrative Physiology, Baylor College of Medicine, Houston, TX 77030, USA.; Texas Heart Institute, Houston, TX 77030, USA., Kim J; Department of Integrative Physiology, Baylor College of Medicine, Houston, TX 77030, USA.; Texas Heart Institute, Houston, TX 77030, USA., Martin JF; Department of Integrative Physiology, Baylor College of Medicine, Houston, TX 77030, USA.; Texas Heart Institute, Houston, TX 77030, USA., Bissig KD; Department of Pediatrics, Alice and Y. T. Chen Center for Genetics and Genomics, Division of Medical Genetics, Duke University, Durham, NC 27710, USA., Jadhav V; Alnylam Pharmaceuticals Inc., Cambridge, MA 02142, USA., Bao G; Department of Bioengineering, Rice University, Houston, TX 77030, USA., Lagor WR; Department of Integrative Physiology, Baylor College of Medicine, Houston, TX 77030, USA.

Journal Article , 2025

Emerging strategies targeting genes and cells in glaucoma.

Roy S; Department of Ophthalmology and Visual Sciences, John A. Moran Eye Center, University of Utah, Salt Lake City, UT, USA. Electronic address: suva.roy@hsc.utah.edu.

Journal Article; Review , 2025

Strategy to Identify Virulence-Related Genes of the Pathogenic Fungus Trichosporon asahii Using an Efficient Gene-Targeting System.

Matsumoto Y; Department of Microbiology, Meiji Pharmaceutical University, Kiyose, Tokyo, Japan., Kurakado S; Department of Microbiology, Meiji Pharmaceutical University, Kiyose, Tokyo, Japan., Yamada T; Teikyo University Institute of Medical Mycology, Teikyo University, Hachioji, Tokyo, Japan.; Asia International Institute of Infectious Disease Control, Teikyo University, Itabashi-ku, Tokyo, Japan., Sugita T; Department of Microbiology, Meiji Pharmaceutical University, Kiyose, Tokyo, Japan.

Journal Article; Review , 2025

G3BP1/2-Targeting PROTAC Disrupts Stress Granules Dependent ATF4 Migracytosis as Cancer Therapy.

Dong T; State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, 2A Nanwei Road, Xicheng District, Beijing 100050, China.; Department of Natural Product Chemistry, Key Laboratory of Chemical Biology the Ministry of Education, School of Pharmaceutical Sciences, Shandong University; Jinan 250012 Shandong Province, China., Zhao F; Department of Medicinal Chemistry, Key Laboratory of Chemical (Biology Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, 44 West Culture Road, Jinan 250012 Shandong, China., Wang M; Department of Natural Product Chemistry, Key Laboratory of Chemical Biology the Ministry of Education, School of Pharmaceutical Sciences, Shandong University; Jinan 250012 Shandong Province, China., Lyu K; State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, 2A Nanwei Road, Xicheng District, Beijing 100050, China., Zhu J; State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, 2A Nanwei Road, Xicheng District, Beijing 100050, China., Zhang W; Department of Natural Product Chemistry, Key Laboratory of Chemical Biology the Ministry of Education, School of Pharmaceutical Sciences, Shandong University; Jinan 250012 Shandong Province, China., Li W; Department of Natural Product Chemistry, Key Laboratory of Chemical Biology the Ministry of Education, School of Pharmaceutical Sciences, Shandong University; Jinan 250012 Shandong Province, China., An Y; Department of Natural Product Chemistry, Key Laboratory of Chemical Biology the Ministry of Education, School of Pharmaceutical Sciences, Shandong University; Jinan 250012 Shandong Province, China., Liu N; Department of Medicinal Chemistry, Key Laboratory of Chemical (Biology Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, 44 West Culture Road, Jinan 250012 Shandong, China., Singh AP; Department of Natural Product Chemistry, Key Laboratory of Chemical Biology the Ministry of Education, School of Pharmaceutical Sciences, Shandong University; Jinan 250012 Shandong Province, China., Yang Y; Department of Medicinal Chemistry, Key Laboratory of Chemical (Biology Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, 44 West Culture Road, Jinan 250012 Shandong, China., Kang D; Department of Medicinal Chemistry, Key Laboratory of Chemical (Biology Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, 44 West Culture Road, Jinan 250012 Shandong, China., Liu X; State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, 2A Nanwei Road, Xicheng District, Beijing 100050, China.

Journal Article , 2025

Ocular Drug Delivery: Overcoming Barriers for Effective Treatment

Nema, Anuradha^Aff4

Pathak, Abhishek^Aff2, Singh, Satya Pal^Aff3, Kang, Y. James^Aff1

Nuclear Morphology-Based Assessment of Cell Fates Induced by a Microtubule Targeting Agent as a Single Treatment or Combined with an Oncolytic Virus

De, Sucheta^Aff3, Ehrlich, Marcelo^Aff3

Padler-Karavani, Vered^Aff2, Walker, John M.^Aff1

A Robust Post-Insertion Method for the Preparation of Targeted Lipid Nanoparticles

Bimbo, Jaime Fernández^{Aff3, Aff4, Aff5}, Schiffelers, Raymond^{Aff4, Aff5}

Zuccheri, Giampaolo^Aff2, Walker, John M.^Aff1